Gene: lnc-IRX3-80
Basic information
LNCipedia gene ID: lnc-IRX3-80
Location (hg19): chr16:54879101-54964854
Strand: -
Class: antisense
Sequence Ontology term: antisense_lncRNA_gene
Transcripts: 66
Transcripts
Transcript ID | Location (hg19) | Length |
---|---|---|
lnc-IRX3-80:1 | chr16:54946684-54964854 | 8903 bp |
lnc-IRX3-80:10 | chr16:54952777-54963101 | 1144 bp |
lnc-IRX3-80:11 | chr16:54939788-54963084 | 18567 bp |
lnc-IRX3-80:12 | chr16:54947340-54963084 | 10739 bp |
lnc-IRX3-80:13 | chr16:54958771-54963084 | 758 bp |
lnc-IRX3-80:14 | chr16:54959065-54963084 | 464 bp |
lnc-IRX3-80:15 | chr16:54952778-54963079 | 1034 bp |
lnc-IRX3-80:16 | chr16:54952969-54963065 | 829 bp |
lnc-IRX3-80:17 | chr16:54952843-54963063 | 1092 bp |
lnc-IRX3-80:18 | chr16:54958771-54963061 | 735 bp |
lnc-IRX3-80:19 | chr16:54958849-54963045 | 641 bp |
lnc-IRX3-80:2 | chr16:54939788-54964490 | 19697 bp |
lnc-IRX3-80:20 | chr16:54953843-54963045 | 1023 bp |
lnc-IRX3-80:21 | chr16:54957193-54962798 | 600 bp |
lnc-IRX3-80:22 | chr16:54949292-54962798 | 13507 bp |
lnc-IRX3-80:23 | chr16:54950099-54962798 | 8332 bp |
lnc-IRX3-80:24 | chr16:54950099-54962798 | 6606 bp |
lnc-IRX3-80:25 | chr16:54952782-54962798 | 749 bp |
lnc-IRX3-80:26 | chr16:54952978-54962798 | 757 bp |
lnc-IRX3-80:27 | chr16:54953085-54962798 | 533 bp |
lnc-IRX3-80:28 | chr16:54957193-54962798 | 600 bp |
lnc-IRX3-80:29 | chr16:54946684-54962750 | 2705 bp |
lnc-IRX3-80:3 | chr16:54939788-54964490 | 18885 bp |
lnc-IRX3-80:30 | chr16:54926848-54962747 | 5766 bp |
lnc-IRX3-80:31 | chr16:54953085-54962724 | 459 bp |
lnc-IRX3-80:32 | chr16:54953172-54962721 | 4544 bp |
lnc-IRX3-80:33 | chr16:54952798-54962708 | 643 bp |
lnc-IRX3-80:34 | chr16:54952782-54962708 | 659 bp |
lnc-IRX3-80:35 | chr16:54952845-54962691 | 496 bp |
lnc-IRX3-80:36 | chr16:54952778-54962690 | 921 bp |
lnc-IRX3-80:37 | chr16:54952777-54962690 | 922 bp |
lnc-IRX3-80:38 | chr16:54952777-54962690 | 850 bp |
lnc-IRX3-80:39 | chr16:54952978-54962628 | 587 bp |
lnc-IRX3-80:4 | chr16:54939788-54964490 | 15622 bp |
lnc-IRX3-80:40 | chr16:54939788-54962476 | 17959 bp |
lnc-IRX3-80:41 | chr16:54952775-54962476 | 627 bp |
lnc-IRX3-80:42 | chr16:54952776-54962476 | 709 bp |
lnc-IRX3-80:43 | chr16:54946684-54962471 | 6796 bp |
lnc-IRX3-80:44 | chr16:54952844-54962463 | 628 bp |
lnc-IRX3-80:45 | chr16:54952798-54962463 | 591 bp |
lnc-IRX3-80:46 | chr16:54952775-54962463 | 614 bp |
lnc-IRX3-80:47 | chr16:54952776-54962463 | 696 bp |
lnc-IRX3-80:48 | chr16:54951851-54962412 | 1498 bp |
lnc-IRX3-80:49 | chr16:54946684-54962241 | 11296 bp |
lnc-IRX3-80:5 | chr16:54939788-54964490 | 18868 bp |
lnc-IRX3-80:50 | chr16:54885425-54962241 | 8721 bp |
lnc-IRX3-80:51 | chr16:54946684-54961572 | 8960 bp |
lnc-IRX3-80:52 | chr16:54953172-54959659 | 6488 bp |
lnc-IRX3-80:53 | chr16:54952872-54959111 | 415 bp |
lnc-IRX3-80:54 | chr16:54885552-54959056 | 2601 bp |
lnc-IRX3-80:55 | chr16:54885425-54958840 | 7213 bp |
lnc-IRX3-80:56 | chr16:54952966-54957691 | 464 bp |
lnc-IRX3-80:57 | chr16:54952782-54954528 | 659 bp |
lnc-IRX3-80:58 | chr16:54885425-54947354 | 2483 bp |
lnc-IRX3-80:59 | chr16:54923451-54927395 | 2340 bp |
lnc-IRX3-80:6 | chr16:54963331-54964490 | 1160 bp |
lnc-IRX3-80:60 | chr16:54881159-54908080 | 865 bp |
lnc-IRX3-80:61 | chr16:54885552-54886645 | 1094 bp |
lnc-IRX3-80:62 | chr16:54881115-54882400 | 719 bp |
lnc-IRX3-80:63 | chr16:54880945-54882209 | 363 bp |
lnc-IRX3-80:64 | chr16:54879101-54882190 | 546 bp |
lnc-IRX3-80:65 | chr16:54881159-54882145 | 420 bp |
lnc-IRX3-80:66 | chr16:54881161-54882145 | 418 bp |
lnc-IRX3-80:7 | chr16:54952844-54963553 | 1442 bp |
lnc-IRX3-80:8 | chr16:54959065-54963101 | 481 bp |
lnc-IRX3-80:9 | chr16:54952777-54963101 | 1057 bp |
Locus conservation
Available literature
- Xie (2016), Long non-coding RNAs in colorectal cancer., Oncotarget
- Cabanski (2015), Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function., RNA Biol
- Chen (2015), Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis., Int J Clin Exp Med
- Maguire (2015), SF3B1 mutations constitute a novel therapeutic target in breast cancer., J. Pathol.
- Pastori (2015), The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation., Proc. Natl. Acad. Sci. U.S.A.
- Ragusa (2015), Non-coding landscapes of colorectal cancer., World J. Gastroenterol.
- Szafron (2015), The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues., PLoS ONE
- Wang (2015), CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling., Cancer Lett.
- Zheng (2015), CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186., Oncotarget
- Barnhill (2014), High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma., Cancer Res.
- Chi (2014), Role of BC040587 as a predictor of poor outcome in breast cancer., Cancer Cell Int.
- Guo (2014), BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition., Oncol Lett
- Roberts (2014), The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease., Philos. Trans. R. Soc. Lond., B, Biol. Sci.
- Furney (2013), SF3B1 mutations are associated with alternative splicing in uveal melanoma., Cancer Discov
- Graham (2011), Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas., Genes Cancer
- Lin (2011), RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders., PLoS ONE